Resonant Capital Advisors, LLC Eli Lilly & CO Transaction History

Resonant Capital Advisors, LLC

$1.34 Billion
Q3 2024

A detailed history of Resonant Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 4,927 shares of LLY stock, worth $3.84 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

4,927

Previous 5,501 10.43%

Holding current value

$3.84 Million

Previous $4.98 Million 12.35%

% of portfolio

0.33%

Previous 0.41%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$772.14 - $960.02 $443,208 - $551,051	-574 Reduced 10.43%	4,927 $4.37 Million
Q2 2024 Aug 01, 2024	BUY	$724.87 - $909.04 $102,931 - $129,083	142 Added 2.65%	5,501 $4.98 Million
Q1 2024 May 01, 2024	BUY	$592.2 - $792.28 $442,373 - $591,833	747 Added 16.2%	5,359 $4.17 Million
Q4 2023 Jan 31, 2024	SELL	$525.19 - $619.13 $134,448 - $158,497	-256 Reduced 5.26%	4,612 $2.69 Million
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $44,339 - $61,128	-102 Reduced 2.05%	4,868 $2.61 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $63,834 - $85,354	182 Added 3.8%	4,970 $2.33 Million
Q1 2023 Apr 21, 2023	BUY	$310.63 - $364.82 $10,872 - $12,768	35 Added 0.74%	4,788 $1.64 Million
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $34,084 - $39,715	-106 Reduced 2.18%	4,753 $0
Q3 2022 Oct 20, 2022	BUY	$296.48 - $337.87 $568,055 - $647,358	1,916 Added 65.1%	4,859 $1.57 Million
Q2 2022 Jul 12, 2022	BUY	$278.73 - $327.27 $121,526 - $142,689	436 Added 17.39%	2,943 $954,000
Q1 2022 Apr 19, 2022	BUY	$234.69 - $291.66 $34,968 - $43,457	149 Added 6.32%	2,507 $734,000
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $49,916 - $61,946	222 Added 10.39%	2,358 $651,000
Q3 2021 Oct 18, 2021	BUY	$221.6 - $272.71 $9,972 - $12,271	45 Added 2.15%	2,136 $494,000
Q2 2021 Jul 16, 2021	BUY	$180.55 - $233.54 $3,791 - $4,904	21 Added 1.01%	2,091 $480,000
Q4 2020 Jan 15, 2021	SELL	$130.46 - $172.63 $19,569 - $25,894	-150 Reduced 6.76%	2,070 $349,000
Q3 2020 Nov 03, 2020	SELL	$146.22 - $169.13 $19,447 - $22,494	-133 Reduced 5.65%	2,220 $329,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $197,027 - $243,864	-1,655 Reduced 41.29%	2,353 $326,000
Q4 2019 Feb 18, 2020	BUY	$106.92 - $132.43 $428,535 - $530,779	4,008 New	4,008 $527,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Resonant Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resonant Capital Advisors, LLC with notifications on news.

Account

Resonant Capital Advisors, LLC Eli Lilly & CO Transaction History